Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-020394
Filing Date
2022-08-12
Accepted
2022-08-12 17:16:49
Documents
61
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q kmph20220630_10q.htm   iXBRL 10-Q 1715046
2 EXHIBIT 31.1 ex_382565.htm EX-31.1 14577
3 EXHIBIT 31.2 ex_382566.htm EX-31.2 14674
4 EXHIBIT 32.1 ex_382567.htm EX-32.1 7120
5 EXHIBIT 32.2 ex_382568.htm EX-32.2 7392
  Complete submission text file 0001437749-22-020394.txt   7821728

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA kmph-20220630.xsd EX-101.SCH 68696
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kmph-20220630_cal.xml EX-101.CAL 50008
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kmph-20220630_def.xml EX-101.DEF 437029
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE kmph-20220630_lab.xml EX-101.LAB 414358
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kmph-20220630_pre.xml EX-101.PRE 461170
55 EXTRACTED XBRL INSTANCE DOCUMENT kmph20220630_10q_htm.xml XML 1363875
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36913 | Film No.: 221161242
SIC: 2834 Pharmaceutical Preparations